Organisation paid for research Program year 2023 Source: CMS Open Payments

Mayo Clinic - Florida

Neither a doctor nor a teaching hospital

Research payments

$1,371,725

161 payments

Through program year 2023, Mayo Clinic - Florida is reported as receiving $1,371,725 in research payments, across 161 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2023	Research	$1,038,673	123
2022	Research	$151,936	20
2021	Research	$181,117	18

Breakdown

Who paid Research payments · program years 2021–2023

Seattle Genetics, Inc. $1,369,017 136 payments
Incyte Corporation $2,708 25 payments

Studies the money was for Research payments · program years 2021–2023

Open-Label Phase 1 Study of SGN-B7H4V for Solid Tumors $815,183 51 payments
A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05) $315,790 37 payments
A Dose-escalation and Dose-expansion Study of Enfortumab Vedotin (ASG-22CE) in Combination With Pembrolizumab and/or Chemotherapy for Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer $217,294 46 payments
A Phase 2 Basket Study of Tucatinib in Combination With Trastuzumab in Subjects With Previously Treated, Locally Advanced Unresectable or Metastatic Solid Tumors Driven by HER2 Alterations $20,750 2 payments
A Randomized, Double-Blind, Multicenter, Phase 2 Study of Retifanlimab in Combination With INCAGN02385 (Anti-LAG-3) and INCAGN02390 (Anti-TIM-3) as First-Line Treatment in Participants With PD-L1-Positive (CPS great than or equal to 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck $2,708 25 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.